Mechanisms of Hepatic Regeneration Following Portal Vein Embolization and Partial Hepatectomy: A Review
The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Background: Portal vein embolization (PVE) improves outcome following major hepatectomy, and basic studies have presented evidence related to the mechanisms responsible for hepatic regeneration. Hemodynamic changes following PVE are similar to, but slightly different from, those of partial hepatectomy (PH) because arterial flow to the embolized lobe is preserved. However, the process of hepatic regeneration is essentially the same after both PVE and PH. A number of mediators are involved in PVE or PH‐induced hepatic regeneration. These include inflammatory cytokines, vasoregulators, growth factors, eicosanoids, and various hormones. These mediators activate a complex network of signal transduction that promotes hepatic regeneration. A variety of conditions have been shown to modulate the function of these mediators and inhibit regeneration. These include biliary obstruction, diabetes, chronic ethanol consumption, malnutrition, gender, aging, and infection. Conclusion: Optimizing these factors, where possible, before PVE or PH, is essential to maximize hypertrophy of the liver. A fuller understanding of hepatic physiology and pathophysiology following PVE or PH may lead to greater functional capacity of the remaining liver and extend the indications for hepatectomy in patients who require large liver volume resection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MAKUUCHI, M., Thai, B. L., Takayasu, K., Takayama, T., Kosuge, T., Gunvén, P., Yamazaki, S., Hasegawa, H., & Ozaki, H. (1990) · PubMed · Cited by 1,241
Nakamura, T., Teramoto, H., & Ichihara, A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.17.6489 · Cited by 582
Nagino, M., Kamiya, J., Nishio, H., Ebata, T., Arai, T., & Nimura, Y. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000201482.11876.14 · Cited by 540 · cited 8×
“Nonetheless, there are cases in which inadequate regeneration after PVE or PH.(89) Further study is needed to identify which factors limit regeneration.”
BackgroundInfluentialSelf-citationLautt, W. W. (1985) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1985.249.5.g549 · Cited by 487 · cited 4×
“Blood flow from the two vessels follows a different pattern intrahepatically, but drains into a terminal hepatic venule as the common drainage vessel.27–31 A decrease in portal venous flow is compensated for by an increase in hepatic arterial flow via the HABR, first described by Lautt et al.5,32 in the 1980s.”
BackgroundInfluentialBraun, L., Mead, J. E., Panzica, M., Mikumo, R., Bell, G. I., & Fausto, N. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1539 · Cited by 479
Preoperative portal vein embolization for hepatocellular carcinoma
Kinoshita, H., Sakai, K., Hirohashi, K., Igawa, S., Yamasaki, O., & Kubo, S. (1986) · World Journal of Surgery · doi:10.1007/bf01655244 · Cited by 452 · cited 1×
“PVE has been used in conjunction with arterial embolization for cases of hepatocellular carcinoma.(3) It was subsequently applied to hepatectomy for metastatic colorectal cancer.”
MethodPreoperative Portal Vein Embolization: An Audit of 84 Patients
Imamura, H., Shimada, R., Kubota, M., Matsuyama, Y., Nakayama, A., Miyagawa, S.-I., Makuuchi, M., & Kawasaki, S. (1999) · Hepatology · doi:10.1002/hep.510290415 · Cited by 367 · cited 4×
“Multiple regression analysis in clinical PVE has shown that diabetes mellitus is a risk factor for reducing the magnitude of hypertrophy in the non-embolized lobe.(48) Insulin gene transfer via the spleen enhances liver regeneration without causing liver damage and improves nutritional status after hepatectomy in diab…”
BackgroundMethodInfluentialRegulation of hepatic regeneration in rats by synergistic action of insulin and glucagon.
Bucher, M. L., & Swaffield, M. N. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.3.1157 · Cited by 328
Rapid activation of the stat3 transcription complex in liver regeneration
Cressman, D. E., Diamond, R. H., & Taub, R. (1995) · Hepatology · doi:10.1002/hep.1840210531 · Cited by 314
Sequential protooncogene expression during rat liver regeneration.
Thompson, N. L., Mead, J. E., Braun, L., Goyette, M., Shank, P. R., & Fausto, N. (1986) · PubMed · Cited by 299
Cited by
Guiu, B., Chevallier, P., Denys, A., Delhom, E., Pierredon-Foulongne, M.-A., Rouanet, P., Fabre, J.-M., Quenet, F., Herrero, A., Panaro, F., et al. (2016) · European Radiology · doi:10.1007/s00330-016-4291-9 · Cited by 205
Hwang, S., Lee, S.-G., Ko, G.-Y., Kim, B.-S., Sung, K.-B., Kim, M.-H., Lee, S.-K., & Hong, H.-N. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e31819ecc5c · Cited by 193
“The mechanism underlying the PVE effect has been associated with a number of mediators, including inflammatory cytokines, vasoregulators, growth factors, eicosanoids, and various hormones.(1) Different conditions have been shown to modulate the functions of these mediators and inhibit regeneration.”
BackgroundHydrogels for Liver Tissue Engineering
Ye, S., Boeter, J. W. B., Penning, L. C., Spee, B., & Schneeberger, K. (2019) · Bioengineering · doi:10.3390/bioengineering6030059 · Cited by 112
Current evidence on posthepatectomy liver failure: Comprehensive review
Sparrelid, E., Olthof, P. B., Dasari, B. V. M., Erdmann, J. I., Santol, J., Starlinger, P., & Gilg, S. (2022) · BJS Open · doi:10.1093/bjsopen/zrac142 · Cited by 88
Metadata
- Authors
- Yokoyama, Y., Nagino, M., & Nimura, Y.
- Venue
- World Journal of Surgery
- Publisher
- Wiley
- Published
- 2007-01-05
- Volume
- 31
- Issue
- 2
- Pages
- 367-374
- ISSN
- 0364-2313 (ISSN-L)
- 1432-2323
- OpenAlex
- W1964391733
- Cited by
- 183
- References
- 63
- FWCI
- 6.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.